MD · Pediatrix Medical Group, Inc.
$26.86
+0.72 (+2.75%)
At close · Jul 28
Market Cap
$2.21B
Shares
82.12M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$250,000,000
as of 2025-08-31
Remaining Authorization
$146,300,000
as of 2026-03-31
Program Utilization
41.5%
$103,700,000 used of $250,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $21,451,000 | 10-Q, filed 2026-05-05 |
| 2025-12-31 | $86,683,000 | 10-K, filed 2026-02-19 |
| 2024-12-31 | $1,703,000 | 10-K, filed 2026-02-19 |
| 2023-12-31 | $919,000 | 10-K, filed 2026-02-19 |
| 2022-12-31 | $88,511,000 | 10-K, filed 2025-02-20 |
| 2021-12-31 | $4,719,000 | 10-K, filed 2024-02-20 |
| 2020-12-31 | $8,493,000 | 10-K, filed 2023-02-17 |
| 2019-12-31 | $145,280,000 | 10-K, filed 2022-02-17 |
| 2018-12-31 | $302,160,000 | 10-K, filed 2021-02-18 |
| 2017-12-31 | $70,192,000 | 10-K, filed 2020-02-20 |
| 2016-12-31 | $61,828,000 | 10-K, filed 2019-02-14 |
| 2015-12-31 | $235,051,000 | 10-K, filed 2018-02-14 |
| 2014-12-31 | $488,429,000 | 10-K, filed 2017-02-10 |
| 2013-12-31 | $51,863,000 | 10-K, filed 2016-02-11 |
| 2008-12-31 | $199,997,000 | 10-K, filed 2011-02-24 |
Key facts
CIK
893949
CUSIP
58502B106
13F (30d)
47 filings
47 filers
Visit website
Investor relations